The trademark application AFFIMED was filed by Affimed GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on May 2, 2022, and it was registered by office on August 9, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1710321 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and address of the trademark registration was recorded on October 5, 2023. Change of name and professional address of the trademark registration was recorded on September 17, 2024.
Goods And Services
The mark was filed in class 1 with Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays (other than for medical or veterinary purposes).
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations
Biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes
Biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells
Biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides
Biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays.
The mark was filed in class 42 with following description of goods:
Scientific and technological services, research and design in the field of immunotherapy, in particular in the field of immuno-oncology
Scientific and technological services, research and design in the field of virology
Scientific and technological services, research and design in the field of antiinfectives
Scientific and technological services, research and design in the field of neurodegenerative diseases
Scientific and technological services, research and design in the field of autoimmune diseases
In particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides
Scientific and technological services, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology